AcneFree

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares were seen soaring 9.3 percent on Tuesday after the company announced the sale of $2.1 billion in assets to raise money to pay down the company’s staggering $30 billion debt load. Divestitures Valeant sold skincare brands CeraVe, AcneFree and...

Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) soared higher by more than 13 percent Tuesday morning after the company agreed to sell multiple business units as part of an ongoing initiative to pay down its debt load, which has some Wall Street analysts deeply concerned. Valeant has agreed...

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) continues its reliance on price as a means of growth as it recently implemented 95 different price increases across more than 50 products. “We continue to believe that the ‘new Valeant’ is the same Valeant using the same strategy and...